For months, demand for Shingrix, the shingles vaccine approved by the FDA in October 2017, has outpaced supply, frustrating patients and providers alike.
[ad_2]
Source link
Commercial Building Financing
For months, demand for Shingrix, the shingles vaccine approved by the FDA in October 2017, has outpaced supply, frustrating patients and providers alike.
[ad_2]
Source link